Preda L, Simioni P, Legnani C, Palareti G, Poggio M, Rossi E, Girolami A
Transfusion Unit, Hospital L. Sacco, Milan, Italy.
Blood Coagul Fibrinolysis. 1996 Jun;7(4):465-9. doi: 10.1097/00001721-199606000-00006.
We have developed a simple screening assay for evaluating the global activity of the protein C/protein S system. The new test consists of measuring the prothrombin time (PT) with bovine thromboplastin before and after activation of the PC present in the plasma sample by PROTAC, derived from Agkistrodon contortrix snake contortrix venom. Prolongation of the PT was directly related to the activity of the PC/PS system. One hundred and nineteen thrombophilic patients including 36 with PC deficiency, 22 with PS defect, 35 with APC resistance and 26 with other genetic defects predisposing to thrombosis were tested with the new assay together with 112 healthy subjects. The new test showed a high sensitivity for detection of inherited defects related to the PC/PS system (92%, 91% and 97% for PC defects, PS defects and APC resistance, respectively). Since it can be performed automatically the test could be used to screen for patients predisposed to thrombosis due to impairment of the PC/PS system and those patients who might eventually require more extensive evaluation of the PC/PS system by single component assays.
我们开发了一种简单的筛查试验,用于评估蛋白C/蛋白S系统的整体活性。新试验包括在用源自矛头蝮蛇毒液的PROTAC激活血浆样本中的蛋白C之前和之后,用牛凝血活酶测量凝血酶原时间(PT)。PT的延长与蛋白C/蛋白S系统的活性直接相关。对119名血栓形成倾向患者(包括36名蛋白C缺乏症患者、22名蛋白S缺陷患者、35名活化蛋白C抵抗患者和26名有其他遗传缺陷易导致血栓形成的患者)以及112名健康受试者进行了新试验检测。新试验对检测与蛋白C/蛋白S系统相关的遗传性缺陷具有高灵敏度(蛋白C缺陷、蛋白S缺陷和活化蛋白C抵抗的灵敏度分别为92%、91%和97%)。由于该试验可以自动进行,因此可用于筛查因蛋白C/蛋白S系统受损而易患血栓形成的患者,以及那些最终可能需要通过单组分试验对蛋白C/蛋白S系统进行更广泛评估的患者。